Ginkor Fort capsules 30 pcs.

• active ingredients: 1 capsule contains Ginkgo biloba dry extract (EGb 761) 14 mg;
• heptaminol hydrochloride 300 mg; troxerutin 300 mg;
• excipients: colloidal anhydrous silicon dioxide, magnesium stearate;
• capsule composition: iron oxide yellow (E 172), indigotine (E 132), titanium dioxide (E 171), gelatin.

Hypersensitivity to active or excipients, gastric and duodenal ulcer, chronic gastritis (in the acute phase).

Since the drug contains heptaminol, it should not be used in hyperthyroidism; also, it should not be used simultaneously with monoamine oxidase inhibitors due to the risk of arterial hypertension.

The following side effects may occur very rarely:

• gastrointestinal disorders: upper abdominal pain, epigastric discomfort, nausea, diarrhea, dyspepsia, flatulence;
• from the nervous system: headache, dizziness, syncope (including vasovagal), sleep disturbances;
• Skin and subcutaneous tissue disorders: hypersensitivity, anaphylactic reactions, including angioedema, urticaria, shortness of breath, itching, allergic dermatitis (eczematous), rash, skin inflammation, redness, ecchymoses; severe allergic reactions;
• general disorders: fatigue;

Cardiac disorders (frequency unknown): hypertension.

Venous-lymphatic insufficiency: prescribe 1 capsule twice a day, morning and evening.

Hemorrhoidal crises: 3–4 capsules per day with meals. Duration of treatment as part of complex therapy is 7 days.

It is advisable to take the medicine with meals.

The drug should be prescribed with caution to patients with severe liver and gallbladder diseases.

Use during pregnancy or breastfeeding

This medicine should not be used during pregnancy due to the vasoactive effect of heptaminol and the anti-aggregatory activity of Ginkgo biloba (EGb 761).

It is not known whether the drug passes into breast milk, so it is not recommended to take it during breastfeeding.

Children

There is insufficient clinical experience with the use of the drug in children, therefore the drug should not be used in pediatric practice.

Ability to influence reaction speed when driving vehicles or other mechanisms

No studies have been conducted to assess the effect on the reaction speed when driving or using other mechanisms. However, dizziness may impair the ability to drive or use other mechanisms.

Symptoms: Adverse reactions may worsen.

Treatment. Stop taking the drug. It is recommended to induce vomiting or perform gastric lavage and carry out symptomatic treatment. If necessary, peritoneal dialysis can be prescribed.

Store in original packaging at a temperature not exceeding 30 ° C. Keep out of the reach of children.